New system that uses AI accurately detects patients with diabetic retinopathy
A system designed by a University of Iowa ophthalmologist that uses artificial intelligence to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration authorization in April, following a clinical trial in primary care offices.